ヤマザキ　ケンジ   KENJI YAMAZAKI   山崎　健二    所属   医学部 医学科（東京女子医科大学病院）    職種   客員教授
言語種別	英語
発表タイトル	Successful withdrawal of implantable left ventricular assist device in a case with major cerebrovascular complication
会議名	The 21st Annual Scientific Meeting of the Japanese Heart Failure Society
主催者	Japanese Heart Failure Society
学会区分	全国規模の学会
発表形式	ポスター掲示
講演区分	一般
発表者・共同発表者	◎KADOWAKI Hiromu, TSUKAMOTO Kei, KIKUCHI Noriko, HATTORI Hidetoshi, SERIZAWA Naoki, NUNODA Shinichi, HAGIWARA Nobuhisa, TATEISHI Monori, SAITO Satoshi, YAMAZAKI Kenji
発表年月日	2017/10/12
開催地 （都市, 国名）	Akita, JAPAN
学会抄録	Journal of Cardiac Failure 23(10),S73 2017
概要	A 55-year-old man with dilated cardiomyopathy (DCM) showed refractory heart failure despite of optical medical therapy and was admitted to our hospital in July 10, 2012. He was registered as a candidate for heart transplantation in Japan, and underwent implantation of a left ventricular assist device (LVAD) (EVAHEART). During the following period, however, he suffered brain hemorrhagic infarction several times and his cognitive function drastically declined, and he had to be moved from Status 1 to 3. Because his recovery on his cardiac function was simultaneously observed (LVEF; 15 to 45%), we tried to wean from LVAD. During this trial, we assessed change of his hemodynamics through by reducing rotation speed of the centrifugal pump and confirmed that no significant hemodynamic worsening was occurred. We successfully removed his LVAD at 1722 days after LVAD implantation, and he has been stable. Destination therapy by LVAD implantation is not approved in Japan and we report successful withdrawal of LVAD in a case with major cerebrovascular complication and showing late recovery of cardiac function.